According to our (Global Info Research) latest study, the global Artificial Intelligence Diagnostics market size was valued at US$ 7469 million in 2025 and is forecast to a readjusted size of US$ 27571 million by 2032 with a CAGR of 20.4% during review period.
Artificial Intelligence Diagnostics refers to regulated software systems that apply machine learning, deep learning, and advanced analytics to clinical data in order to support or deliver diagnostic decisions. Unlike general clinical analytics, AI diagnostics are designed to influence medical judgment by identifying disease, assessing severity, or recommending diagnostic conclusions based on inputs such as medical imaging, physiological signals (e.g., ECG, EEG), ophthalmic images, laboratory patterns, and multi-modal clinical data. Most solutions are commercialized as Software as a Medical Device (SaMD) and operate under strict regulatory frameworks such as FDA clearance or CE marking. AI diagnostics do not replace physicians but function as decision-support or physician-in-the-loop systems, improving diagnostic accuracy, speed, and consistency across healthcare settings.
Artificial Intelligence Diagnostics refers to regulated software systems that apply machine learning, deep learning, and advanced analytics to
The market can be classified by diagnostic data type (imaging-based, physiological signal-based, ophthalmic, multi-modal), by diagnostic role (screening, diagnostic assistance, automated diagnosis, severity assessment, therapy guidance), by clinical specialty (radiology, cardiology, neurology, ophthalmology, oncology, primary care), by deployment model (standalone SaMD, cloud SaaS, device-embedded, edge or wearable-based), and by regulatory/commercial type (FDA/CE-cleared diagnostic AI, clinical decision support, screening-only solutions).
Upstream players include medical device OEMs, sensor and imaging hardware suppliers, cloud and GPU infrastructure providers, and healthcare institutions contributing annotated clinical datasets. Midstream consists of AI diagnostics developers responsible for algorithm design, clinical validation, regulatory approval, and system integration with hospital IT. Downstream customers are hospitals, diagnostic centers, physician groups, and population-health programs, purchasing AI diagnostics through enterprise software contracts, bundled device sales, or subscription platforms.
Key costs arise from data acquisition and labeling, clinical trials, regulatory compliance, and continuous model maintenance. Due to software-driven economics, gross margins typically range from 65% to 80%. Transactions are dominated by subscription SaaS, per-use pricing, and multi-year enterprise licenses, increasingly bundled with devices or workflow platforms. Market trends include rapid expansion beyond radiology into cardiology and primary care, accelerated regulatory approvals, consolidation through M&A, and rising adoption driven by clinician shortages and value-based care models.
This report is a detailed and comprehensive analysis for global Artificial Intelligence Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Intelligence Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Intelligence Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Intelligence Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Butterfly Network, Merative, Tempus, RetinAi, Nanox, Lunit, DiA Imaging, Subtle Medical, BrainMiner, GE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Artificial Intelligence Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Services
Software
Hardware
Market segment by Diagnostic Data Type
Medical Imaging–based
Physiological Signals–based
Ophthalmic Imaging–based
Others
Market segment by Deployment & Delivery
On-prem
Cloud SaaS
Edge / Embedded
Hybrid
Others
Market segment by Application
Radiology
Oncology
Neurology
Cardiology
Chest & Lungs
Others
Market segment by players, this report covers
Butterfly Network
Merative
Tempus
RetinAi
Nanox
Lunit
DiA Imaging
Subtle Medical
BrainMiner
GE
Siemens
Aidoc
Imagen Technologies, Inc.
VUNO, Inc.
Digital Diagnostics
NeuraSignal
Riverain Technologies, LLC
Philips
Microsoft
Viz.ai
RapidAI
Canon Medical
Enlitic
BioMind
ANNALISE-AI PTY LTD
icometrix
KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Intelligence Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Intelligence Diagnostics, with revenue, gross margin, and global market share of Artificial Intelligence Diagnostics from 2021 to 2026.
Chapter 3, the Artificial Intelligence Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Intelligence Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence Diagnostics.
Chapter 13, to describe Artificial Intelligence Diagnostics research findings and conclusion.
Summary:
Get latest Market Research Reports on Artificial Intelligence Diagnostics. Industry analysis & Market Report on Artificial Intelligence Diagnostics is a syndicated market report, published as Global Artificial Intelligence Diagnostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Artificial Intelligence Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.